Trial intelligence / Profile preview

Pilot of Zinc Acetate to Improve Chronic Cough

NCT03135522Phase 2Completed

Sponsor
Johns Hopkins University
Start
Feb 2018
Primary completion
Dec 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in refractory chronic cough (RCC) comparing Zinc Acetate with Placebo (2 arms). Primary endpoint: Cough Specific Quality of Life Questionnaire at 6 weeks. Started Feb 2018; status: completed.

02

Drugs

zinc acetate
03

Conditions

refractory chronic cough (RCC)

Beyond the preview

Go deeper on NCT03135522.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03135522.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call